GLIOGENE is an international consortium of familial brain tumor researchers in the United States, the United Kingdom, Sweden, Denmark and Israel. With GLIOGENE, we may be able learn more about possible genes related to this disease -- and then identify a genetic link among family members of brain tumor patients. Identifying a genetic link may provide information about the disease -- information that one day we hope will lead to improved treatment, as well as preventive strategies.

GLIOGENE is the largest study ever to be conducted on familial gliomas, or primary brain tumors. Researchers aim to screen approximately 15,000 individuals worldwide during the five-year study. Find out more...

MD ANDERSON NEWS

  • Personalized treatment for ovarian cancer
    Download from iTunes: https://itunes.apple.com/us/podcast/personalized-treatment-for/id431848216?i=321325068&mt=2 MD Anderson Cancer Center now has a more strategic approach to treating ovarian cancer which results in a 68% higher rate...
  • Wilms' tumor: childhood kidney cancer
    Listen now: http://www3.mdanderson.org/streams/AudioPlayer.cfm?mediaID=8164D178-A143-4864-8B90-55904613BE8B  Wilms' tumor is a cancer that develops in the kidney and is the fifth most common cancer in children. Generally there are...
  • Prostate Cancer Moon Shot update
    Download from iTunes: https://itunes.apple.com/us/podcast/prostate-cancer-moon-shot/id431848216?i=319769359&mt=2. The Prostate Cancer Moon Shot at MD Anderson Cancer Center focuses on: reducing overtreatment; combining therapies used in more advanced cases...